Literature DB >> 1331042

Enhancement of membrane insertion and function in a type IIIb membrane protein following introduction of a cleavable signal peptide.

X M Guan1, T S Kobilka, B K Kobilka.   

Abstract

The human beta 2 adrenergic receptor is a type IIIb membrane protein. It has a putative seven-transmembrane topology but lacks an amino-terminal cleavable signal sequence. The mechanism by which the amino terminus of the beta 2 receptor is translocated across the endoplasmic reticulum membrane is unknown. Furthermore, it is not known if translocation as a type IIIb protein is essential for the proper folding. Our studies indicate that conversion of beta 2 receptor from a type IIIb to a type IIIa membrane protein by introducing an NH2-terminal cleavable signal sequence enhances translocation of the receptor into the endoplasmic reticulum membrane, thereby facilitating expression of functional receptor.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1331042

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  73 in total

1.  Constitutive activation of tethered-peptide/corticotropin-releasing factor receptor chimeras.

Authors:  S M Nielsen; L Z Nielsen; S A Hjorth; M H Perrin; W W Vale
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

2.  A PTEN-Regulated Checkpoint Controls Surface Delivery of δ Opioid Receptors.

Authors:  Daniel J Shiwarski; Alycia Tipton; Melissa D Giraldo; Brigitte F Schmidt; Michael S Gold; Amynah A Pradhan; Manojkumar A Puthenveedu
Journal:  J Neurosci       Date:  2017-03-06       Impact factor: 6.167

3.  The micromolar zinc-binding domain on the NMDA receptor subunit NR2B.

Authors:  Julie Rachline; Florent Perin-Dureau; Anne Le Goff; Jacques Neyton; Pierre Paoletti
Journal:  J Neurosci       Date:  2005-01-12       Impact factor: 6.167

4.  Structural genomics on membrane proteins: comparison of more than 100 GPCRs in 3 expression systems.

Authors:  Kenneth Lundstrom; Renaud Wagner; Christoph Reinhart; Aline Desmyter; Nadia Cherouati; Thierry Magnin; Gabrielle Zeder-Lutz; Melanie Courtot; Cécile Prual; Nicolas André; Gherici Hassaine; Hartmut Michel; Christian Cambillau; Franc Pattus
Journal:  J Struct Funct Genomics       Date:  2006-11-22

5.  Protein sorting by lipid phase-like domains supports emergent signaling function in B lymphocyte plasma membranes.

Authors:  Matthew B Stone; Sarah A Shelby; Marcos F Núñez; Kathleen Wisser; Sarah L Veatch
Journal:  Elife       Date:  2017-02-01       Impact factor: 8.140

6.  The structural basis of G-protein-coupled receptor signaling (Nobel Lecture).

Authors:  Brian Kobilka
Journal:  Angew Chem Int Ed Engl       Date:  2013-05-06       Impact factor: 15.336

7.  Molecular identification of the human melanocortin-2 receptor responsible for ligand binding and signaling.

Authors:  Min Chen; Charles J Aprahamian; Robert A Kesterson; Carroll M Harmon; Yingkui Yang
Journal:  Biochemistry       Date:  2007-09-18       Impact factor: 3.162

8.  Amino acid sequence conservation of the algesic fragment of myelin basic protein is required for its interaction with CDK5 and function in pain.

Authors:  Andrei V Chernov; Albert G Remacle; Swathi K Hullugundi; Piotr Cieplak; Mila Angert; Jennifer Dolkas; Veronica I Shubayev; Alex Y Strongin
Journal:  FEBS J       Date:  2018-08-27       Impact factor: 5.542

9.  Recruitment of beta-arrestin2 to the dopamine D2 receptor: insights into anti-psychotic and anti-parkinsonian drug receptor signaling.

Authors:  Ib V Klewe; Søren M Nielsen; Louise Tarpø; Eneko Urizar; Concetta Dipace; Jonathan A Javitch; Ulrik Gether; Jan Egebjerg; Kenneth V Christensen
Journal:  Neuropharmacology       Date:  2008-04-08       Impact factor: 5.250

10.  Role of the G-protein-coupled receptor GPR12 as high-affinity receptor for sphingosylphosphorylcholine and its expression and function in brain development.

Authors:  Atanas Ignatov; Julia Lintzel; Irm Hermans-Borgmeyer; Hans-Jürgen Kreienkamp; Patrick Joost; Susanne Thomsen; Axel Methner; H Chica Schaller
Journal:  J Neurosci       Date:  2003-02-01       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.